Literature DB >> 12926988

Involvement of LEU13 in interferon-induced refractoriness of human RSa cells to cell killing by X rays.

K Kita1, S Sugaya, L Zhai, Y P Wu, C Wano, S Chigira, J Nomura, S Takahashi, M Ichinose, N Suzuki.   

Abstract

Culture of human cells with human interferon alpha and beta (IFNA and IFNB) results in increased resistance of the cells to cell killing by X rays. To identify candidate genes responsible for the IFN-induced X-ray resistance, we searched for genes whose expression levels are increased in human RSa cells treated with IFNA, using an mRNA differential display method and Northern blotting analysis. RSa cells, which showed increased survival (assayed by colony formation) after X irradiation when they were treated with IFNA prior to irradiation, showed increased expression levels of LEU13 (IFITM1) mRNA after IFNA treatment alone. In contrast, IF(r) and F-IF(r) cells, both of which are derived from RSa cells, showed increased X-ray resistance and high constitutive LEU13 mRNA expression levels compared to the parental RSa cells. Furthermore, the IFNA-induced resistance of RSa cells to killing by X rays was suppressed by antisense oligonucleotides for LEU13 mRNA. LEU13, a leukocyte surface protein, was previously reported to mediate the actions of IFN such as inhibition of cell proliferation. The present results suggest a novel role of LEU13 different from that in the inhibition of cell proliferation, involved in IFNA-induced refractoriness of RSa cells to X rays.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12926988     DOI: 10.1667/rr3039

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  12 in total

Review 1.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.

Authors:  Rosalba Camicia; Hans C Winkler; Paul O Hassa
Journal:  Mol Cancer       Date:  2015-12-11       Impact factor: 27.401

2.  STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells.

Authors:  Nikolai N Khodarev; Michael Beckett; Edwardine Labay; Thomas Darga; Bernard Roizman; Ralph R Weichselbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-30       Impact factor: 11.205

Review 3.  Functional Interfaces, Biological Pathways, and Regulations of Interferon-Related DNA Damage Resistance Signature (IRDS) Genes.

Authors:  Monikaben Padariya; Alicja Sznarkowska; Sachin Kote; Maria Gómez-Herranz; Sara Mikac; Magdalena Pilch; Javier Alfaro; Robin Fahraeus; Ted Hupp; Umesh Kalathiya
Journal:  Biomolecules       Date:  2021-04-22

4.  STAT1 pathway mediates amplification of metastatic potential and resistance to therapy.

Authors:  Nikolai N Khodarev; Paul Roach; Sean P Pitroda; Daniel W Golden; Mihir Bhayani; Michael Y Shao; Thomas E Darga; Mara G Beveridge; Ravi F Sood; Harold G Sutton; Michael A Beckett; Helena J Mauceri; Mitchell C Posner; Ralph R Weichselbaum
Journal:  PLoS One       Date:  2009-06-08       Impact factor: 3.240

5.  TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.

Authors:  Michael Hajek; Andrew Sewell; Susan Kaech; Barbara Burtness; Wendell G Yarbrough; Natalia Issaeva
Journal:  Cancer       Date:  2017-03-13       Impact factor: 6.860

Review 6.  Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance.

Authors:  Shuya Liu; Saber Imani; Youcai Deng; Janak L Pathak; Qinglian Wen; Yue Chen; Jingbo Wu
Journal:  Onco Targets Ther       Date:  2020-06-24       Impact factor: 4.147

7.  Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling.

Authors:  Elena V Efimova; Hua Liang; Sean P Pitroda; Edwardine Labay; Thomas E Darga; Vera Levina; Anna Lokshin; Bernard Roizman; Ralph R Weichselbaum; Nikolai N Khodarev
Journal:  Int J Radiat Biol       Date:  2009-05       Impact factor: 2.694

8.  In vivo functional requirement of the mouse Ifitm1 gene for germ cell development, interferon mediated immune response and somitogenesis.

Authors:  Ingeborg Klymiuk; Lukas Kenner; Thure Adler; Dirk H Busch; Auke Boersma; Martin Irmler; Barbara Fridrich; Valérie Gailus-Durner; Helmut Fuchs; Nicole Leitner; Mathias Müller; Ralf Kühn; Michaela Schlederer; Irina Treise; Martin Hrabě de Angelis; Johannes Beckers
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

9.  Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer.

Authors:  Martin Buess; Dimitry S A Nuyten; Trevor Hastie; Torsten Nielsen; Robert Pesich; Patrick O Brown
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

10.  Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset.

Authors:  Paul R Dominguez-Gutierrez; Angela Ceribelli; Minoru Satoh; Eric S Sobel; Westley H Reeves; Edward K L Chan
Journal:  Arthritis Res Ther       Date:  2014-01-24       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.